Skip to main content
CRIS
NASDAQ Life Sciences

Curis Posts $8.1M Q3 Loss, Zero Revenue; Cash Lasts Into Q1 2027

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.572
Mkt Cap
$3.818M
52W Low
$0.325
52W High
$28.398
52W Position info
76% above low
Off High info
98% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

CRIS sits 76% above its 52-week low of $0.325 on light trading volume (0.1× avg).

Summary

Curis reported a Q3 net loss of $8.1M versus $7.7M a year earlier, with revenue at zero against $3.2M in Q3 2025 after the 2025 sale of Erivedge royalties. The nine-month loss widened to $40.9M from $26.9M, and the company held just $5.0M in cash at September 30. Management says the roughly $7.5M in net October placement proceeds stretch the runway into Q1 2027 — a modest extension for a company that already carries going-concern doubt. The per-share loss fell to $1.94 from $9.86, reflecting the July 1-for-20 reverse split rather than any improvement in the business. The one thing that could change the story is initial TakeAim CLL data expected in December 2026, with 12 patients enrolled so far.

At the time of this announcement, CRIS was trading at $0.57 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.8M. The 52-week trading range was $0.33 to $28.40. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CRIS - Latest Insights

CRIS
Nov 13, 2026, 4:19 PM EST
Filing Type: S-3
Importance Score:
7
Price at Filing: $0.445
Real-time Price: $0.4498 info
Change: +$0.0048 (+1%) info
Market Cap: $2.972M info
CRIS
Nov 13, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.445
Real-time Price: $0.4498 info
Change: +$0.0048 (+1%) info
Market Cap: $2.972M info
CRIS
Nov 06, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.8481
Real-time Price: $0.4498 info
Change: -$0.3983 (-47%) info
Market Cap: $2.972M info
CRIS
Oct 19, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3816
Real-time Price: $0.4498 info
Change: +$0.0682 (+18%) info
Market Cap: $2.972M info
CRIS
Oct 16, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.5333
Real-time Price: $0.4498 info
Change: -$0.0835 (-16%) info
Market Cap: $2.972M info